Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

This randomized trial evaluated ferric carboxymaltose without erythropoiesis-stimulating agents (ESA) for correction of anemia in cancer patients with functional iron deficiency. Patients on treatment for indolent lymphoid malignancies, who had anemia [hemoglobin (Hb) 8.5–10.5 g/dL] and functional i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedenus, Michael, Karlsson, Torbjörn, Ludwig, Heinz, Rzychon, Beate, Felder, Marcel, Roubert, Bernard, Birgegård, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221625/
https://www.ncbi.nlm.nih.gov/pubmed/25373320
http://dx.doi.org/10.1007/s12032-014-0302-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221625/
https://www.ncbi.nlm.nih.gov/pubmed/25373320
http://dx.doi.org/10.1007/s12032-014-0302-3

Ejemplares similares